AGM Poll Results

GlaxoSmithKline PLC
17 May 2004

Issued - Monday 17th May 2004, London - LSE Announcement




                      GlaxoSmithKline plc - Results of AGM

GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all
resolutions, including those electing and re-electing Board members, were passed
by shareholders.


Commenting on the results Sir Christopher Hogg, Chairman of GlaxoSmithKline said
"I'm very pleased that all the resolutions have been passed by such a
substantial majority."


              GlaxoSmithKline Annual General Meeting Poll Results

The following table shows the votes cast for each resolution:



                                                  %        Total votes      %      Total votes cast   Abstentions**  
         Resolution          Total votes for*                against     
                                             
  1.     Adoption of             3,772,569,153    98.61       53,133,367     1.39      3,825,702,520      126,825,561 
         Financial                                                                                                    
         Statements                                                                                                   

  2.     Approval of the         3,256,510,243    89.49      382,337,135    10.51      3,638,847,378      314,504,441 
         Remuneration                                                                                                 
         Report                                                                                                       

  3.     Election of Mr H        3,915,556,226    99.46       21,302,704     0.54      3,936,858,930       15,669,151 
         L Culp                                                                                                       

  4.     Election of Mr C        3,915,875,382    99.46       21,323,427     0.54      3,937,198,809       15,329,272 
         Davis                                                                                                        

  5.     Election of Sir         3,916,386,157    99.45       21,552,354     0.55      3,937,938,511       14,589,570 
         Robert Wilson                                                                                                

  6.     Election of Dr T        3,861,633,390    99.33       26,051,285     0.67      3,887,684,675       64,843,406 
         Yamada                                                                                                       

  7.     Re-election of          3,876,671,124    98.83       45,713,506     1.17      3,922,384,630       30,143,451 
         Sir Christopher                                                                                              
         Hogg                                                                                                         

  8.     Re-appointment of       3,758,892,246    99.32       25,819,263     0.68      3,784,711,509      167,816,572 
         Auditors                                                                                                     

  9.     Remuneration of         3,918,517,277    99.48       20,305,032     0.52      3,938,822,309       13,705,772 
         Auditors                                                                                                     

  10.    Authorise               3,843,373,653    97.99       78,986,180     2.01      3,922,359,833       30,168,248 
         donations to EU                                                                                              
         Political                                                                                                    
         Organisations &                                                                                              
         incur EU                                                                                                     
         Political                                                                                                    
         Expenditure                                                                                                  

  11.    Disapplication of       3,904,964,468    99.00       39,246,915     1.00      3,944,211,383        8,316,698 
         pre-emption                                                                                                  
         rights***                                                                                                    

  12.    Authority for the       3,882,768,808    99.45       21,328,838     0.55      3,904,097,646       48,430,435 
         Company to                                                                                                   
         purchase its own                                                                                             
         shares***                                                                                                    

Notes:  

*     Includes discretionary votes.  

**     An abstention is not a vote in law and is not counted in the calculation of the proportion of votes "For" or
       "Against" a resolution. 
***     Indicates Special Resolutions requiring a 75% majority 
 


The following table provides further relevant information: 
                                                                                                                      
                                                                                                                      
                                                                              GlaxoSmithKline's    GlaxoSmithKline's  
                                                                              Fourth AGM (2004)     Third AGM (2003)  

  Issued share capital                                                             5,921,564,431        6,001,763,774 
  (excluding Treasury Shares)                                                                                         

  Total votes cast and abstentions lodged as a % of GSK's issued share                    66.75%               63.23% 
  capital (excluding Treasury Shares).                                                                                

  Total shareholder population.                                                          230,939              241,420 

  Total number of proxies lodged.                                                         17,400               18,560 

  % of shareholders who lodged proxies.                                                    7.53%                7.69% 

  Number of shareholders, corporate representatives and proxies who                          349                  532 
  attended the AGM                                                                                                    
 
S M Bicknell 
Company Secretary 
17th May 2004 


These results will shortly be available on the Company's website www.gsk.com. 
Enquiries: 

                                                                                                   
                     UK Media enquiries:                     Martin Sutton        [phone]  
                                                             David Mawdsley       [phone]  
                                                             Chris Hunter-Ward    [phone]  

                     US Media enquiries:                     Nancy Pekarek        [phone]   
                                                             Mary Anne Rhyne      [phone]   
                                                             Patricia Seif        [phone]   

                     European Analyst/Investor enquiries:    Duncan Learmouth     [phone]  
                                                             Anita Kidgell        [phone]  
                                                             Philip Thomson       [phone]  

                     US Analyst/ Investor enquiries:         Frank Murdolo        [phone]   
                                                             Tom Curry            [phone]   
 
 
END  




                      This information is provided by RNS
            The company news service from the London Stock Exchange